What question did this study set out to answer?

To determine the role of ALKBH5 in ovarian cancer progression and its mechanism of action.

March 6, 2026Biological Procedures Online0 citationsOpen Access

ALKBH5 promotes ovarian cancer progression by activating Notch2 signaling

Key Points

To determine the role of ALKBH5 in ovarian cancer progression and its mechanism of action.
Analyzed ALKBH5 expression levels in ovarian cancer samples
Examined the relationship between ALKBH5 and Notch2 signaling
Investigated the potential of ALKBH5 as a biomarker and therapeutic target.
ALKBH5 expression was significantly higher in ovarian cancer tissues compared to normal tissues.
Activation of Notch2 signaling was correlated with increased ALKBH5 levels.
Potential use of ALKBH5 as a prognostic biomarker and therapeutic target was identified.

Abstract

In summary, our findings demonstrated that ALKBH5 promotes the progression of ovarian cancer by activating Notch2 signaling, and suggested that ALKBH5 functions as an oncogene and may serve as a prognostic biomarker and therapeutic target in ovarian cancer.

Demander à l'IA

Bookmark

View Full Paper